SUBSTITUTED ARYLIMIDAZ0L0NE AND TRIAZ0L0NE AS INHIBITORS OF VASOPRESSIN RECEPTORS.

摘要

The present application relates to new, substituted 4-Arylimidazol-2-one and 5-Aryl-l,2,4-triazolone, a method for their production, their use alone or in combination in treating and/or preventing diseases, as well as their use in producing medicaments for treating and/or preventing diseases, in particular cardiovascular diseases.